Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BXL-628 in post-menopausal women with overactive bladder
2004-000609-23Phase 2Completed
- Sponsor
- Bioxell GmbH
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in overactive bladder (OAB) comparing BXL-628 with Placebo (2 arms). Started Mar 2005; status: completed.
02
Drugs
elocalcitol
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2004-000609-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000609-23.